Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AgelessRx vs Found

By GLP-1 ScorecardUpdated

AgelessRx
Site position #17

Higher score

FoundFactor scores not reassessed.
Site position #7

Lower score

Score comparison

AgelessRx has the higher recorded score — 84.3/100 to 83.5/100, but only just.

AgelessRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Conventional and microdose GLP-1 programs with continuing care; branded prescriptions involve a separate pharmacy payment. Found is close behind and may still be the better fit — see the factor split below.

Before you choose

AgelessRx does not publish a semaglutide price, so its AgelessRx review sets out what it does disclose, while the Found review explains the conditions attached to Found's figure. The semaglutide cost page compares published rates across the field. Ask AgelessRx for a written total before treating either one as the cheaper choice.

If neither one fits, AgelessRx vs Fridays and Allara Health vs Found compare each of them with another graded program, and the list of alternatives to AgelessRx ranks the programs closest to AgelessRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueAgelessRx +12
90
78
Dose & formulationFound +14
80
94
Clinical oversightFound +3
83
86
Labs & monitoringEven
82
82
FulfillmentEven
84
84
Contract termsAgelessRx +15
85
70
AgelessRx · top barFound · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricAgelessRxFound
WeighScore84.3/10083.5/100
GradeBB
Site position#17#7
SemaglutideNot verified (current medication-specific quote required)$149 first, then $269 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms)
TirzepatideMicrodose: $109 first month, then $318 every 2 months ($159/mo); full-dose quote required$199 first, then $339 every 28 days on the one-term cash compounded plan (labs extra; confirm selected terms)
CoverageAdvertises US service; confirm treatment-specific state availabilityU.S. service with state, treatment and insurance restrictions; confirm your eligibility
Brand-name accessYesYes
Oral / sublingualYesYes
AgelessRx

Site position #17 · B

Strengths

  • Conventional and lower-dose GLP-1 programs advertised
  • Wegovy pens and oral-tablet consultations advertised
  • Continuing messaging and check-ins advertised

What to consider

  • Conventional medication-specific monthly quotes not verified
  • Microdose introduction renews as a two-month charge
  • Branded medication has a separate pharmacy bill
  • Treatment-specific state eligibility and assigned dispenser need confirmation
Found

Site position #7 · B

Factor scores not reassessed.

Strengths

  • Current compounded offers include medication, membership and care, with separate semaglutide and tirzepatide price tables
  • Branded injection and oral options are listed, subject to prescription, stock and patient-specific terms
  • Insurance-track clinical visits and cash-pay care are distinguished in the public billing documents
  • Terms name possible independent medical groups and describe check-ins and messaging

What to consider

  • Cash compounded renewal rates differ by molecule and recur every 28 days, not a calendar month
  • Longer-term advertised rates and upfront-payment wording do not settle the selected charge or supply
  • Labs cost extra; insurance-track cost-sharing can add to the bill and does not reimburse compounded-medication fees
  • Refund wording about three days and the first consultation conflicts; rejection of a preferred GLP-1 is not disqualification from all treatment
  • The assigned compounder, actual treating practice and individual license status remain unresolved
  • A brand or oral menu listing does not establish a specific available prescription, complete price or clinical equivalence

Featured provider

Found

Factor scores not reassessed.

Found scores 83.5/100 (B). Found offers compounded, brand-name and oral GLP-1 routes, but their bills differ: compounded plans include medication and care, while branded medication and labs cost extra.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard